Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)

British Journal of Dermatology

Volumn 174, Issue 2, 2016, Pages 287-295

  Schmitt, Jochen ^a,b   Deckert, S ^a   Alam, M ^c   Apfelbacher, C ^d   Barbaric, J ^e   Bauer, A ^f   Chalmers, J ^b   Chosidow, O ^g,h,i,j   Delamere, F ^b   Doney, E ^b   Eleftheriadou, V ^b   Grainge, M ^k   Johannsen, L ^a   Kottner, J ^l   Le Cleach, L ^g,h,i,j   Mayer, A ^m   Pinart, M ^n,o,p,q   Prescott, L ^b   Prinsen, C A C ^r   Ratib, S ^b   Schlager, J G ^l   Sharma, M ^s   Thomas, K S ^b   Weberschock, T ^t,u   Weller, K ^l   Werner, R N ^l   Wild, T ^v   Wilkes, S R ^b   Williams, H C ^b   more..

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e Agency for Quality and Accreditation in Health Care   (Croatia)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g HENRI MONDOR HOSPITAL   (France)

^h UNIVERSITÉ PARIS EST CRÉTEIL   (France)

ⁱ Satellite Français du Cochrane Skin Group   (France)

^j Centre d'Investigation Clinique   (France)

^k UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^o HOSPITAL DEL MAR   (Spain)

^p UNIVERSITAT POMPEU FABRA   (Spain)

^q CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^r VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^s DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^t UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^u GOETHE UNIVERSITY   (Germany)

^v DESSAU MEDICAL CENTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CONFERENCE PAPER; CORE OUTCOME SET; DERMATOLOGY; EVIDENCE BASED PRACTICE; GERMANY; HUMAN; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; INTERNATIONAL COOPERATION; ORGANIZATION; PROCEDURES; PUBLIC RELATIONS; STANDARDS;

CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DERMATOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL COOPERATION; INTERPROFESSIONAL RELATIONS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE;

EID: 84962204134     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14337     Document Type: Conference Paper

References (27)

1. Elliot JH, Turner T, Clavisi O, et al,. Living systematic reviews: an emerging oppurtunity to narrow the evidence-practice gap. PLoS Med 2014; 18: e1001603.
2. Grimshaw JM, Eccles MP, Lavis JN, et al,. Knowledge translation of research findings. Implement Sci 2012; 7: 50.
3. Chalmers I, Glasziou P,. Avoidable waste in the production and reporting of research evidence. Obstet Gynecol 2009; 114: 1341-5.
4. Guyatt GH, Oxman AD, Vist GE, et al,. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
5. Roekevisch E, Spuls PI, Kuester D, et al,. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol 2014; 133: 429-38.
6. Schmitt J, Langan S, Williams HC,; European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120: 1389-98.
7. Simpson RC, Thomas KS, Murphy R,. Outcome measures for vulval skin conditions: a systematic review of randomized controlled trials. Br J Dermatol 2013; 169: 494-501.
8. Eleftheriadou V, Thomas KS, Whitton ME, et al,. Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo. Br J Dermatol 2012; 167: 804-14.
9. Clarke M,. Standardising outcomes for clincal trials and systematic reviews. Trials 2007; 8: 39.
10. Boers M, Kirwan JR, Tugwell P, et al,. The OMERACT Handbook. Available at: http://www.omeract.org/pdf/OMERACT-Handbook.pdf (last accessed 9 November 2015).
11. Kirkham JJ, Gargon E, Clarke M, Williamson PR,. Can a core outcome set improve the quality of systematic reviews?-A survey of the Co-ordinating Editors of Cochrane Review Groups. Trials 2013; 14: 21.
12. Schmitt J, Apfelbacher C, Spuls P, et al,. The Harmonising Outcomes for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol 2014; 135: 24-30.
13. Gottlieb AB, Levin AA, Armstrong AW, et al,. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology. J Am Acad Dermatol 2015; 72: 345-8.
14. Cochrane Skin. Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). Available at: http://skin.cochrane.org/core-outcomes-set-initiative-csg-cousin (last accessed 9 November 2015).
15. Center for Evidence-Based Healthcare. Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). Available at: https://www.uniklinikum-dresden.de/zegv/cousin (last accessed 9 November 2015).
16. Cochrane Skin. CSG annual meeting 2015. Available at: http://skin.cochrane.org/csg-annual-meeting-2015 (last accessed 9 November 2015).
17. Chalmers JR, Schmitt J, Apfelbacher C, et al,. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol 2014; 171: 1318-25.
18. Schmitt J, Langan S, Stamm T, et al,. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol 2011; 131: 623-30.
19. Schmitt J, Spuls P, Boers M, et al,. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67: 1111-17.
20. Schmitt J, Williams H,; HOME Development Group. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163: 1166-8.
21. Mokkink LB, Terwee CB, Patrick DL, et al,. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-49.
22. Mokkink LB, Terwee CB, Patrick DL, et al,. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010; 63: 737-45.
23. Terwee CB, Bot SD, de Boer MR, et al,. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
24. Eleftheriadou V, Thomas K, van Geel N, et al,. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res 2015; 28: 363-9.
25. Schmitt J, Spuls PI, Thomas KS, et al,. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic ezcema in trials. J Allergy Clin Immunol 2014; 134: 800-7.
26. Apfelbacher CJ, Heinl D, Prinsen CA, et al,. Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review. Syst Rev 2015; 4: 48.
27. Olliaro P, Vaillant M, Arana B, et al,. Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis 2013; 7: e2130.